InsidersTradesSigma
Explore the detailed record of transactions filed by Wood Gavin, Chief Financial Officer. Officer active across 1 companies, notably Adaptimmune Therapeutics PLC. In total, 1 filings have been published. Total volume traded: €11k. The latest transaction was disclosed on 20 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Wood Gavin is the Chief Financial Officer at Adaptimmune Therapeutics PLC. He is responsible for the financial management of the company, including financial planning and reporting. His expertise is essential to support the company's growth and profitability.